Johnson & Johnson and 4 Important Healthcare Stocks You Must Analyze After Earnings

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Johnson & Johnson (NYSE:JNJ) delivered a profit, YET came up short on beating the revenue expectation. Net income increased 1078.9% to $2.57 billion (91 cents per diluted share) in the quarter versus a net gain of $218 million in the year-earlier quarter. Revenue Rose 8.58% to $17.65 billion from the year-earlier quarter.

Johnson & Johnson reported adjusted net income of $1.19 cents per share. By that measure, the company beat the mean analyst estimate of $1.17. It missed the average revenue estimate of $17.67 billion.

JNJ

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business